Skip to main content
Equibles

GREAT POINT PARTNERS LLC

Position in RARE — Ultragenyx Pharmaceutical Inc.

CIK 1281446 Greenwich, CT
Back to RARE Full portfolio

Position in RARE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
-$6,900,000 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
7 quarters on record

Common Shares in RARE Over Time

Shares Held

Position Value (USD)

Derivatives in RARE

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
0
PutValue
$20,034,000
PutShares
600,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GREAT POINT PARTNERS LLC holds $397,271,949 across 33 Biotechnology names.

# Ticker Company Shares Value (USD) Open
1 VOR
Vor Biopharma Inc.
 1,700,000 $31,297,000
2 ABVX
Abivax S.A.
 204,314 $27,226,883
3 VERA
Vera Therapeutics, Inc.
 600,836 $25,781,872
4 ZURA
Zura Bio Ltd
 4,215,930 $24,873,987
5 ALMS
Alumis Inc.
 856,061 $24,089,556
6 SLGL
Sol-Gel Technologies Ltd.
 274,363 $20,341,272
7 DFTX
Definium Therapeutics, Inc.
 425,000 $19,992,000
8 ANNX
Annexon, Inc.
 3,500,000 $19,985,000

All Filings in RARE

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $20,034,000 600,000
2025-12-31 $6,900,000 300,000
2023-12-31 $30,987,360 648,000
2023-09-30 $25,932,736 727,426
2023-06-30 $31,249,661 677,426
2023-03-31 $27,164,782 677,426
2022-12-31 $15,858,759 342,300